← Leaderboards
Valerie Johnson
Weill Medical College Of Cornell Univ
$815
Attributed
$815
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$815 · 3
By mechanism
M01$815 · 3
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Michael P Wajnrajch$731,405
- Phyllis August$679,164
- Randi Beth Silver$3,563,422
- Norman R. Relkin$3,431,964
- Manikkam Suthanthiran$17,019,909
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationClinical ResearchHuman SubjectChronic Renal FailureUrinalysisBone MetabolismChild (0-11)DosageDrug Screening /EvaluationDwarfismGlomerulonephritisHormone TherapyImmunoglobulinsImmunotherapyInsulinlike Growth FactorIntravenous AdministrationPathologic ProcessRecombinant ProteinsSomatotropinUnited States National Institutes Of HealthComplement 3 Nephritic FactorAutoantibodiesResearch PersonnelImmunoglobulins, Intravenous
Grant awards (7)
INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF MEMBRANOPROLIFERATIVE$815
M01 · FY2007 · RR · contact PI
IV IMMUNOGLOBULIN THERAPY OF GLOMERULONEPHRITIS$0
M01 · FY2002 · RR
GH/IGF AXIS AND BONE TURNOVER IN CHILDREN WITH CRF AND ESRD$0
M01 · FY2002 · RR
IV IMMUNOGLOBULIN THERAPY OF GLOMERULONEPHRITIS$0
M01 · FY2001 · RR
GH/IGF AXIS AND BONE TURNOVER IN CHILDREN WITH CRF AND ESRD$0
M01 · FY2001 · RR
GH/IGF AXIS AND BONE TURNOVER IN CHILDREN WITH CRF AND ESRD$0
M01 · FY2000 · RR
IV IMMUNOGLOBULIN THERAPY OF GLOMERULONEPHRITIS$0
M01 · FY2000 · RR